BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

746 related articles for article (PubMed ID: 18619695)

  • 1. Cost-effectiveness analysis and innovation.
    Jena AB; Philipson TJ
    J Health Econ; 2008 Sep; 27(5):1224-36. PubMed ID: 18619695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stratified cost-effectiveness analysis: a framework for establishing efficient limited use criteria.
    Coyle D; Buxton MJ; O'Brien BJ
    Health Econ; 2003 May; 12(5):421-7. PubMed ID: 12720259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care technology adoption and diffusion in a social context.
    Coyte PC; Holmes D
    Policy Polit Nurs Pract; 2007 Feb; 8(1):47-54. PubMed ID: 17470771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striking a balance on new technology. Cost-effectiveness analysis can help sort out emerging health care technologies, but what are the consequences for continued medical innovation?
    Philipson TJ; Jena AB
    AHIP Cover; 2006; 47(5):29, 31, 33. PubMed ID: 17007325
    [No Abstract]   [Full Text] [Related]  

  • 5. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical context of technology assessment.
    Smits HL
    J Health Polit Policy Law; 1984; 9(l):31-40. PubMed ID: 11650667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managed care in the Organization for Economic Cooperation and Development countries: prospects for quality, effectiveness, and equity.
    Nolan B
    Health Care Manag; 1995 Oct; 2(1):125-42. PubMed ID: 10165627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
    Wallner PE; Konski A
    J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To use technology better.
    Garber AM
    Health Aff (Millwood); 2006; 25(2):w51-3. PubMed ID: 16464903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decisions to adopt new technologies at the hospital level: insights from Israeli medical centers.
    Greenberg D; Peterburg Y; Vekstein D; Pliskin JS
    Int J Technol Assess Health Care; 2005; 21(2):219-27. PubMed ID: 15921062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constructive Technology Assessment (CTA) as a tool in coverage with evidence development: the case of the 70-gene prognosis signature for breast cancer diagnostics.
    Retèl VP; Bueno-de-Mesquita JM; Hummel MJ; van de Vijver MJ; Douma KF; Karsenberg K; van Dam FS; van Krimpen C; Bellot FE; Roumen RM; Linn SC; van Harten WH
    Int J Technol Assess Health Care; 2009 Jan; 25(1):73-83. PubMed ID: 19126254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Big ticket health technology: is rational utilization possible?
    Johansen KS; Racoveanu NT
    Med Prog Technol; 1991; 17(2):85-91. PubMed ID: 1835754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technological and social innovation: a unifying new paradigm for global health.
    Gardner CA; Acharya T; Yach D
    Health Aff (Millwood); 2007; 26(4):1052-61. PubMed ID: 17630448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.
    Laupacis A; Feeny D; Detsky AS; Tugwell PX
    CMAJ; 1992 Feb; 146(4):473-81. PubMed ID: 1306034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health system and equity perspectives in health technology assessment.
    Hanvoravongchai P
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S74-87. PubMed ID: 19253490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and implementation of health technology assessment in Argentina: two steps forward and one step back.
    Rubinstein A; Pichon-Riviere A; Augustovski F
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():260-9. PubMed ID: 19527545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Static and dynamic efficiency of irreversible health care investments under alternative payment rules.
    Levaggi R; Moretto M; Pertile P
    J Health Econ; 2012 Jan; 31(1):169-79. PubMed ID: 22019114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalised cost-effectiveness analysis: an aid to decision making in health.
    Hutubessy RC; Baltussen RM; Torres-Edejer TT; Evans DB
    Appl Health Econ Health Policy; 2002; 1(2):89-95. PubMed ID: 14619255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theory and methods of economic evaluation of health care.
    Johannesson M
    Dev Health Econ Public Policy; 1996; 4():1-245. PubMed ID: 10158916
    [No Abstract]   [Full Text] [Related]  

  • 20. Productive innovations in hospitals: an empirical research on the relation between technology and productivity in the Dutch hospital industry.
    Blank JL; Van Hulst BL
    Health Econ; 2009 Jun; 18(6):665-79. PubMed ID: 18702093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.